Lifeboat Foundation

We’d like to draw attention to an initiative whose objectives are close to our own: the German Party for Health Research (GPHR, Partei für Gesundheitsforschung in German). Founded in January 2015 by three biochemists and one actor, the GPHR is rather unique in that it is a single-issue party: its only concern is the creation of effective therapies to treat and prevent the pathologies of old age.

Since its creation, the party has participated in five elections; one of its biggest successes was the Berlin state elections in September 2016, where it received 0.5% of the secondary votes despite being still a rather unknown party. Slowly but steadily, the party has enjoyed an increase in voter support over the years, doing even better than the well-known Pirate Party in one election district during the 2017 federal elections. Currently, the party counts over 250 members, a very heterogeneous group of young and old people with different backgrounds.

The GPHR was founded because the founding members, including biochemist Felix Werth, wanted to give people a new way to support research against age-related diseases; not everyone is willing or capable to help the cause in traditional ways, such as by donating money or time to research or advocacy organizations, while a political party offers simpler yet effective ways to help, such as voting for the party, signing for its participation in elections, or even joining for free as a member.

Continue reading “The German Party for Health Research Enters Elections” »

Here’s a look at 20 of the most exciting areas of research on aging to watch in 2019 and beyond.

Unity Biotech’s drug to treat an intractable arthritic condition is in late-stage human trials.

Follow the life, death, and groundbreaking 3D resurrection of Susan Potter whose body became a high resolution digital cadaver.
➡ Subscribe: http://bit.ly/NatGeoSubscribe

#NationalGeographic #SusanPotter #DigitalCadaver

Continue reading “How a Woman’s Donated Body Became a Digital Cadaver | National Geographic” »

Great news for Repair Biotechnologies a new startup company developing solutions to age-related immune system decline and heart disease.

In 2018, Reason and Bill Cherman founded Repair Biotechnologies, which, as its name suggests, is a rejuvenation biotechnology company focused on damage repair approaches to aging. The company has recently completed a seed round of investment funding, with a total of $2.15 million being put into the company’s coffers to bolster research and development. Reason described this seed round as follows:

We are very pleased to have the support of noted investors such as Jim Mellon. They are the people who are presently providing the fuel and publicity for ever faster progress in the longevity biotechnology industry.

Continue reading “Repair Biotechnologies Raises a $2.15M Seed Round” »

Longevity companies have often risen and fallen with little ado. But if these financial experts are correct that biotech companies are poised to start “bringing unprecedented increases to the quality and length of human lifespans,” per CNBC, then we may start seeing serious results out of the industry.

“New Frontier”

Bank of America’s predictions would mean a six-fold increase in the amount of money in longevity companies. In a report to clients reviewed by CNBC, analysts wrote that the human lifespan may soon extend to 100 years.

Continue reading “Major Bank: The Immortality Industry Is the Next Hot Investment” »

Longevity technology number one, according to the Longevity Impact Forum rating, proven by Patient zero.

Liz Parrish, CEO of BioViva USAa short clip from her gene therapy that she took in 2015 against biological aging. This is the first step to curing diseases like Alzheimer’s disease, heart disease, kidney failure and cancer. If we work toward this goal quickly we could save almost 8 billion people from inhumane and expensive deaths.
https://www.BioViva-Science.com
https://www.Integrated-Health-Systems.com

Continue reading “BioViva -- First Gene Therapy To Treat Biological Aging -- Patient Zero — Liz Parrish” »

In his 1971 State of the Union address, president Richard Nixon promised to kick off what would soon come to be known as the War on Cancer, asking congress for a $100 million appropriation to launch a campaign for finding a cure. “The time has come in America when the same kind of concentrated effort that split the atom and took man to the moon should be turned toward conquering this dread disease,” he said. “Let us make a total national commitment to achieve this goal.”

Welcome to the War on Aging, where death is optional.

Circa 1998

CELL BIOLOGY
F or cells, aging and cancer are often opposite sides of a genetic coin: With “heads,” cells will eventually stop dividing, reaching a permanently quiescent stage called senescence, as do normal human cells in lab cultures. With “tails,” the cells with genetic defects can become immortal and never stop dividing—a common characteristic of cultured cancer cells. Now, a group at Baylor College of Medicine in Houston has found a gene that may help determine which side the coin lands on.

![Figure][1]/img.

Continue reading “Immortality Gene Discovered” »